457 related articles for article (PubMed ID: 14533449)
1. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial and behavioral impact of genetic counseling and testing.
Vadaparampil ST; Miree CA; Wilson C; Jacobsen PB
Breast Dis; 2006-2007; 27():97-108. PubMed ID: 17917142
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.
Kash KM; Ortega-Verdejo K; Dabney MK; Holland JC; Miller DG; Osborne MP
Semin Surg Oncol; 2000 Jun; 18(4):333-8. PubMed ID: 10805955
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial aspects of genetic counseling and testing.
Vadaparampil ST; Wey JP; Kinney AY
Semin Oncol Nurs; 2004 Aug; 20(3):186-95. PubMed ID: 15491028
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Godard B; Pratte A; Dumont M; Simard-Lebrun A; Simard J
Genet Test; 2007; 11(1):45-54. PubMed ID: 17394392
[TBL] [Abstract][Full Text] [Related]
8. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.
Lessick M
Nurs Womens Health; 2007 Aug; 11(4):390-9; quiz 400-1. PubMed ID: 17883756
[No Abstract] [Full Text] [Related]
10. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
12. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
[TBL] [Abstract][Full Text] [Related]
13. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial issues associated with increased breast and ovarian cancer risk: findings from focus groups.
Pasacreta JV
Arch Psychiatr Nurs; 1999 Jun; 13(3):127-36. PubMed ID: 10389341
[TBL] [Abstract][Full Text] [Related]
15. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
[TBL] [Abstract][Full Text] [Related]
16. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
[TBL] [Abstract][Full Text] [Related]
17. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
18. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.
Hopwood P
Curr Opin Oncol; 2005 Jul; 17(4):340-4. PubMed ID: 15933464
[TBL] [Abstract][Full Text] [Related]
20. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
